| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 502,853 | 478,584 | 540,817 | 500,077 | | Cost of Revenue | 112,956 | 91,187 | 149,180 | 179,313 | | | Gross Profit | 389,897 | 387,397 | 391,637 | 320,764 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 79,122 | 66,179 | 60,089 | 35,902 | | Non Recurring |
-
|
-
| 907,812 |
-
| | Others | 113,737 | 118,991 | 124,228 | 113,930 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 197,038 | 202,227 | (700,492) | 170,932 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 554 | 169 | 365 | 1,874 | | Earnings Before Interest And Taxes | 197,592 | 202,374 | (700,105) | 172,766 | | Interest Expense | 5,277 | 3,066 | 3,684 | 1,800 | | Income Before Tax | 192,315 | 199,308 | (703,789) | 170,966 | | Income Tax Expense | 74,105 | 78,272 | (270,959) | 66,767 | | Minority Interest | 108 | (22) | 22 | (40) | | | | Net Income From Continuing Ops | 118,318 | 121,036 | (432,830) | 104,199 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 118,318 | 121,036 | (432,830) | 104,199 | | Preferred Stock And Other Adjustments | (64) | 64 |
-
|
-
| | | Net Income Applicable To Common Shares | $118,254 | $121,100 | ($432,830) | $104,199 |
|
0.31% Nasdaq 
0.05%
Income Statement
